InvestorsHub Logo
Followers 14
Posts 818
Boards Moderated 1
Alias Born 11/13/2019

Re: None

Monday, 07/24/2023 7:47:06 AM

Monday, July 24, 2023 7:47:06 AM

Post# of 21
$QNCX - Up 10% Pre-Market/ Current Price $1.75
To Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent QNCX News